Story
UK Competition Watchdog Launches Review of Akzo Nobel's Axalta Takeover

Summary
The UK's Competition and Markets Authority (CMA) has initiated a phase 1 review of the proposed all-stock merger between coatings giants Akzo Nobel and Axalta. The regulator will decide by November 11 whether the deal requires a more in-depth investigation.
The United Kingdom's competition regulator has officially begun its review of the proposed merger between Dutch paint and coatings company Akzo Nobel and its U.S.-based rival, Axalta Coating Systems. The move marks a critical step in the regulatory approval process for a deal that would combine two major players in the global coatings industry.
Regulatory Scrutiny Begins
The Competition and Markets Authority (CMA) announced on Wednesday that it had accepted the merger notice, formally starting its initial "phase 1" investigation. The review period began on September 17.
The regulator has set a deadline of November 11 to decide whether the transaction could substantially lessen competition within any UK market. Following its initial assessment, the CMA will either clear the merger to proceed or refer it for a more extensive "phase 2" investigation.
Deal Status and Timeline
AdThe proposed transaction is an all-stock merger that has already received the green light from shareholders of both companies, who voted in favor of the deal on August 5. According to the companies, the final voting results are to be filed with the U.S. Securities and Exchange Commission.
Despite shareholder approval, the merger's completion remains subject to other regulatory clearances and customary closing conditions. The companies currently expect the transaction to be finalized in late 2026 or early 2027, pending the outcome of reviews like the one initiated by the CMA.
What This Means for Investors
The CMA's review is a standard but crucial hurdle for large-scale mergers. A potential referral to a phase 2 investigation could introduce significant delays and uncertainty for the deal, creating a potential headwind for the shares of both Akzo Nobel and Axalta. Investors will be closely monitoring the CMA's decision in November as a key indicator of the regulatory landscape for the acquisition.
Read next
More on Stocks
West Faces Soaring Prices, Supply Gaps for Critical Metals Three Years After Chinese Curbs
Three years after Beijing restricted exports of gallium and germanium, Western nations face prices up to ten times 2023 levels and a significant supply deficit, despite efforts to launch new production.

Goldman Sachs Downplays S&P 500 'Earnings Bubble' Fears, Forecasts Slower Growth
Goldman Sachs analysts argue that while some U.S. corporate profits are elevated, the S&P 500 is not in an "earnings bubble" and is poised for continued, albeit slower, growth driven by profits rather than valuation expansion.

TSX Futures Edge Higher as Falling Oil Prices Temper Inflation Concerns
Futures for Canada's main stock index saw a slight increase, supported by a third consecutive day of declines in crude oil prices, which has eased investor concerns about persistent inflation.

Morgan Stanley Downgrades Orange on Slower Growth, Rising Leverage Concerns
Morgan Stanley has downgraded French telecom operator Orange SA to "underweight," citing a projected slowdown in profit growth, increased balance sheet leverage, and intensifying competition in Spain.